 There's a new option tonight for people with Alzheimer's disease. The Food and Drug Administration approved a second Alzheimer's drug. It's made by Eli Lilly and it's called Kesunla and is for mild or early cases of dementia caused by Alzheimer's. Kesunla is only the second drug that's been convincingly shown to delay cognitive decline in patients.